The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

By sjmartinez • March 25, 2025

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi T, Pillinger MH, Riggs KR, Saag KG, Shekelle PG, Tseng Z, Toprover M, Wei DS, Barry MJ, Choi HK. The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. ACR Open Rheumatol. 2025 Mar;7(3):e70012. doi: 10.1002/acr2.70012. PMID: 40126890.

Tags: General Internal Medicine, Publications, Rheumatology, Veterans Administration

Correction: A workshop considering genetic research and data collection with American Indian and Alaska Native people outside of tribal jurisdiction

Beans JA, Blanchard J, Hiratsuka V, Helton T, Carroll S, Dillard D, Orr R, Gachupin FC, Hull S, Haring RC, Garrison NA, Saukeah B, Tsosie[...]

Psychological factors as mediators of the effectiveness of telehealth mindfulness-based interventions for pain and pain-related conditions

Taylor SL, Calvert C, Haley AC, Evans R, Adamowicz J, Allen KD, Bronfort G, Cross LJS, Goldsmith ES, Grant A, Leininger B, Matthias MS, Serpa[...]

Maintaining control: challenges and facilitators to medication adherence among young adults with HIV and recent criminal legal system experience or high risk for system involvement

Mungo L, Harawa NT, Seiden D, McAvoy-Banerjea J, Wang L, Brewer RA, Belzer M. Maintaining control: challenges and facilitators to medication adherence among young adults[...]